Cyclooxygenase-2 expression and angiogenesis in squamous cell carcinoma of the skin and its precursors: a paired immunohistochemical study of 35 cases.
about
Myricetin inhibits UVB-induced angiogenesis by regulating PI-3 kinase in vivo.Angiogenesis in the progression of cutaneous squamous cell carcinoma: an immunohistochemical study of endothelial markers.Aspirin for the primary prevention of skin cancer: A meta-analysisAnalgesic and nonsteroidal anti-inflammatory use in relation to nonmelanoma skin cancer: a population-based case-control study.Morphology of angiogenesis in human cancer: a conceptual overview, histoprognostic perspective and significance of neoangiogenesis.Preventative topical diclofenac treatment differentially decreases tumor burden in male and female Skh-1 mice in a model of UVB-induced cutaneous squamous cell carcinomaPresent concepts and future outlook: function of peroxisome proliferator-activated receptors (PPARs) for pathogenesis, progression, and therapy of cancer.The role of apoptosis in therapy and prophylaxis of epithelial tumours by nonsteroidal anti-inflammatory drugs (NSAIDs).Angiogenesis in pre-malignant conditionsEmerging drugs for actinic keratosis.Cyclooxygenase-dependent signaling is causally linked to non-melanoma skin carcinogenesis: pharmacological, genetic, and clinical evidence.Peroxisome proliferator-activated receptors (PPARs) in dermatology: Challenge and promise.Actinic keratosis: a clinical and epidemiological revision.Peroxisome proliferator-activated receptors (PPARs) and PPAR agonists: the 'future' in dermatology therapeutics?Immunohistochemical study of cyclooxygenase-2 in skin tumors.Association of functional gene variants in the regulatory regions of COX-2 gene (PTGS2) with nonmelanoma skin cancer after organ transplantation.Immunohistochemical Analysis of Cyclooxygenase-2 in Non-Melanocytic Skin Cancer: Correlation With Morphological Subtype and Histologic Grade.Vasohibin-1 as a potential predictor of aggressive behavior of ductal carcinoma in situ of the breast.Juglanin ameliorates UVB‑induced skin carcinogenesis via anti‑inflammatory and proapoptotic effects in vivo and in vitro.Genetically determined susceptibility to COX-2 inhibitors: a report of exaggerated responders to diclofenac 3% gel in the treatment of actinic keratoses.Treatment of multiple actinic keratoses with topical diclofenac 3% gel in organ transplant recipients: a series of six cases.Expression of Cyclooxygenase-2 in Squamous Cell Carcinoma and Keratoacanthoma and its Clinical Significance.Oral acetylsalicylic acid and prevalence of actinic keratosis
P2860
Q33829163-A7B133E1-AB20-41C6-A01B-0DA780B4F883Q34768754-F5C643E5-4EC5-4D23-99B3-F8CD8CBFD480Q35041988-BDF5913A-F5EE-4A0E-84D7-5ED8C8F9362FQ35119206-977694B6-2A6E-4B21-AE1F-34CF9E983ED1Q36103175-CEC7AA8D-E6CE-4F1F-9885-B35C4BD35393Q36587639-5FA89F20-9D6B-45DE-9745-9DD3EBB48D04Q36795404-A1BC5B72-1B75-47B3-A279-58DE844290FAQ36815314-0E33953B-F3B5-4DEB-BA1C-83EB6CD39527Q37305411-65D212E6-112A-4280-B8A3-D2FA339D212DQ37776509-640264C8-BD9F-4A28-A024-AF1FA242E198Q37950866-A91EC1B9-657A-4D96-BC01-B487E0A93FDEQ37959975-4A853D54-8232-425F-99F0-B77FBCAD64E2Q38020129-BE19A379-DC4C-4E3A-ABFF-F50727BC6A8CQ38489705-8FB1A528-127F-402D-9C8C-57A6C2635DE8Q42507472-7F21DB08-B697-4962-838D-1B8E29714EF3Q42514306-AC46C247-43B3-42AF-B033-3C17456DAE7CQ44919731-98DDA083-15E4-46FB-A4DC-C22A75530872Q51547813-F39109DA-3077-495E-A441-B50DF204DD80Q52721412-25AA0BB8-F2B3-4FD4-9346-ADD1136A60E4Q52926191-E91B9FC9-0919-47BF-B645-588449E47C2FQ52926198-BECC1777-9C75-42CA-8CF1-84D1FC23BC9BQ53648177-8734AF3C-0045-40EB-815C-3822DE15410FQ57274746-DE6FFF93-4976-45C7-8DA1-95533A7FA4F8
P2860
Cyclooxygenase-2 expression and angiogenesis in squamous cell carcinoma of the skin and its precursors: a paired immunohistochemical study of 35 cases.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Cyclooxygenase-2 expression an ...... stochemical study of 35 cases.
@en
Cyclooxygenase-2 expression an ...... stochemical study of 35 cases.
@nl
type
label
Cyclooxygenase-2 expression an ...... stochemical study of 35 cases.
@en
Cyclooxygenase-2 expression an ...... stochemical study of 35 cases.
@nl
prefLabel
Cyclooxygenase-2 expression an ...... stochemical study of 35 cases.
@en
Cyclooxygenase-2 expression an ...... stochemical study of 35 cases.
@nl
P2093
P2860
P1476
Cyclooxygenase-2 expression an ...... stochemical study of 35 cases.
@en
P2093
Colpaert CG
Van Marck E
Vermeulen PB
P2860
P304
P356
10.1111/J.1365-2133.2004.06214.X
P407
P577
2004-10-01T00:00:00Z